# Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors

> **NCT07487883** · — · RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer
- Malignant Neoplasm
- Pulmonary Nodules
- PET/CT

## Interventions

- **DIAGNOSTIC_TEST:** PET/CT scans

## Key facts

- **NCT ID:** NCT07487883
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-18
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-07-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07487883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07487883, "Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07487883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*